{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:33:53Z","timestamp":1760099633416},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,2,1]],"date-time":"1988-02-01T00:00:00Z","timestamp":570672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1988,2]]},"DOI":"10.1007\/bf00915889","type":"journal-article","created":{"date-parts":[[2005,1,2]],"date-time":"2005-01-02T04:09:10Z","timestamp":1104638950000},"page":"25-35","source":"Crossref","is-referenced-by-count":38,"title":["Substance-P-like levels in inflammatory exudates"],"prefix":"10.1007","volume":"12","author":[{"given":"M.","family":"Tissot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pradelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Giroud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"85","volume":"35","author":"B. Pernow","year":"1983","unstructured":"Pernow, B. 1983. Substance P.Pharmacol. Rev. 35:85?141.","journal-title":"Pharmacol. Rev."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000137979","volume":"28","author":"D. Regoli","year":"1984","unstructured":"Regoli, D., E. Escher, andJ. Mizrahi. 1984. Substance P?structure-activity studies and the development of antagonists.Pharmacology 28:301?320.","journal-title":"Pharmacology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","volume":"72","author":"U. S. Euler von","year":"1931","unstructured":"Euler, U. S. von, andJ. H. Gaddum. 1931. An unidentified depressor substance in certain tissue extracts.J. Physiol. (London).72:74?87.","journal-title":"J. Physiol. (London)"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1748-1716.1936.tb01459.x","volume":"73","author":"U. S. Euler von","year":"1936","unstructured":"Euler, U. S. von. 1936. Preparation of substance P.Scand. Arch. Physiol. 73:142?144.","journal-title":"Scand. Arch. Physiol."},{"key":"CR5","first-page":"731","volume-title":"Advances in Hepatic Encephalopathy and Urea Cycle Diseases","author":"H. Hortnaol","year":"1984","unstructured":"Hortnaol, H., E. A. Singer, K. Lenz, G. Kleinberger, andH. Lochs. 1984. Involvement of substance P in the pathogenesis of cardiovascular complications in hepatic failure.In Advances in Hepatic Encephalopathy and Urea Cycle Diseases. G. Kleinberger, P. Ferenci, P. Riederer, and H. Thaler, editors. Karger, Basel. 731?739."},{"key":"CR6","first-page":"169","volume-title":"Substance P","author":"F. Lembeck","year":"1977","unstructured":"Lembeck, F., R. Gamse, andH. Juan. 1977. Substance P and sensory nerve endings.In Substance P. U.S. von Euler and B. Pernow, editors. Raven Press, New York. 169?181."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0306-4522(78)90116-1","volume":"3","author":"A. Ljungdahl","year":"1978","unstructured":"Ljungdahl, A., T. Hokfelt, andG. Nilsson. 1978. Distribution of substance P-like immunoreactivity in the central nervous system of the rat.Neuroscience 3:861?976.","journal-title":"Neuroscience"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0006-291X(81)90727-0","volume":"99","author":"W. A. Marasco","year":"1981","unstructured":"Marasco, W. A., H. J. Showell, andE. L. Becker. 1981. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil.Biochem. Biophys. Res. Commun. 99:1065?1072.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0006-291X(80)90581-1","volume":"94","author":"Z. Bar-Shavit","year":"1980","unstructured":"Bar-Shavit, Z., R. Goldman, Y. Stabinsky, P. Gottlieb, M. Fridkin, V. I. Teichberg, andS. Blumberg. 1980. Enhancement of phagocytosis?a newly found activity of substance P residing in itsN-terminal tetrapeptide sequence.Biochem. Biophys. Res. Commun. 94:1445?1451.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(83)90511-3","volume":"89","author":"H. P. Hartung","year":"1983","unstructured":"Hartung, H. P., andK. V. Toyka. 1983. Activation of macrophages by substance P: Induction of oxidative burst and thromboxane release.Eur. J. Pharmacol. 89:301?305.","journal-title":"Eur. J. Pharmacol."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4049\/jimmunol.131.4.1613","volume":"131","author":"D. G. Payan","year":"1983","unstructured":"Payan, D. G., D. R. Brewster, andE. J. Goetzl. 1983. Specific stimulation of human T-lymphocytes by substance P.J. Immunol. 131:1613?1615.","journal-title":"J. Immunol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111567","volume":"74","author":"D. G. Payan","year":"1984","unstructured":"Payan, D. G., D. R. Brewster, A. Missirian-Bastian, andE. J. Goetzl. 1984. Substance P recognition by a subset of human T lymphocytes.J. Clin. Invest. 74:1532?1539.","journal-title":"J. Clin. Invest."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00501166","volume":"318","author":"C. M. Lee","year":"1982","unstructured":"Lee, C. M., L. L. Iversen, M. R. Hanley, andB. E. B. Sandberg. 1982. The possible existence of multiple receptors for substance P.Arch. Pharmacol. 318:281?287.","journal-title":"Arch. Pharmacol."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0024-3205(84)90403-X","volume":"35","author":"S. P. Watson","year":"1984","unstructured":"Watson, S. P. 1984. Are the proposed substance P receptor sub-types, substance P receptors?Life Sci. 35:797?808.","journal-title":"Life Sci."},{"key":"CR15","first-page":"1","volume":"16","author":"T. M. Jesell","year":"1983","unstructured":"Jesell, T. M. 1983. Substance P in the nervous system.Hand. Neuropharmacol. 16:1?105.","journal-title":"Hand. Neuropharmacol."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.ne.03.030180.001303","volume":"3","author":"R. A. Nicoll","year":"1980","unstructured":"Nicoll, R. A., C. Schenker, andS. E. Leeman. 1980. Substance P as a transmitter candidate.Annu. Rev. Neurosci. 3:227?268.","journal-title":"Annu. Rev. Neurosci."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1101\/SQB.1976.040.01.015","volume":"40","author":"M. Otsuka","year":"1976","unstructured":"Otsuka, M., andS. Konishi. 1976. Substance P and excitatory transmitter of primary sensory neurons.Cold Spring Harbor Symp. Quant. Biol. 40:135?143.","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"CR18","first-page":"1074","volume":"34","author":"R. Gamse","year":"1984","unstructured":"Gamse, R. 1984. Physiologie und Pathophysiologie der Substanz P.Arzneim-Forsch. Drug Res. 34:1074?1079.","journal-title":"Arzneim-Forsch. Drug Res."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00500282","volume":"310","author":"F. Lembeck","year":"1979","unstructured":"Lembeck, F., andP. Holzer. 1979. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation.Arch. Pharmacol. 310:175?183.","journal-title":"Arch. Pharmacol."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0143-4179(81)90013-5","volume":"1","author":"F. Lembeck","year":"1981","unstructured":"Lembeck, F., J. Donnerer, andF. C. Colpaert. 1981. Increase in substance P in primary afferent nerves during chronic pain.Neuropeptides 1:175?181.","journal-title":"Neuropeptides"},{"key":"CR21","first-page":"149","volume-title":"Takykinin Antagonists","author":"A. Saria","year":"1985","unstructured":"Saria, A., R. Gamse, J. M. Lundberg, T. Hokfelt, E. Theodorsson-Norheim, J. Petermann, andJ. A. Fischer. 1985. Co-existence of tachykinins and calcitonin-gene-related peptide in sensory nerves in relation to neurogenic inflammation.In Takykinin Antagonists. R. Hakanson and F. Sundler, editors. Elsevier, Amsterdam. 149?157."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-2999(85)90475-3","volume":"117","author":"P. Devillier","year":"1985","unstructured":"Devillier, P., M. Renoux, J. P. Giroud, andD. Regoli. 1985. Peptides and histamine release from rat peritoneal mast cells.Eur. J. Pharmacol. 117:89?96.","journal-title":"Eur. J. Pharmacol."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4889(85)90102-8","volume":"846","author":"H. Shibata","year":"1985","unstructured":"Shibata, H., M. Mio, andK. Tasaka. 1985. Analysis of the mechanism of histamine release induced by substance P.Biochem. Biophys. Acta 846:1?7.","journal-title":"Biochem. Biophys. Acta"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00502084","volume":"82","author":"G. Skofitsch","year":"1985","unstructured":"Skofitsch, G., J. M. Savitt, andD. M. Jacobowitz. 1985. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery.Histochemistry 82:5?8.","journal-title":"Histochemistry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.6208609","volume":"226","author":"J. D. Levine","year":"1984","unstructured":"Levine, J. D., R. Clark, M. Devor, C. Helms, M. A. Moskowitz, andA. I. Basbaum. 1984. Intraneuronal substance P contributes to the severity of experimental arthritis.Science 226:547?549.","journal-title":"Science"},{"key":"CR26","first-page":"406","volume":"12","author":"J. D. Levine","year":"1985","unstructured":"Levine, J. D., D. H. Collier, A. I. Basbaum, M. A. Moskowitz, andC. A. Helms. 1985. Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis.J. Rheumatol. 12:406?411.","journal-title":"J. Rheumatol."},{"key":"CR27","first-page":"399","volume":"12","author":"L. L. Iversen","year":"1985","unstructured":"Iversen, L. L. 1985. The possible role of neuropeptides in the pathophysiology of rheumatoid arthritis.J. Rheumatol. 12:399?400.","journal-title":"J. Rheumatol."},{"key":"CR28","first-page":"69","volume-title":"Vasal, Humoral and Cellular Aspects of Inflammation and Inhibition of Inflammation","author":"A. Langner","year":"1984","unstructured":"Langner, A., H. Schumann, H. Bekemeier, P. Oehme, andR. Rathsack. 1984. Substance P?a potential mediator of inflammation.In Vasal, Humoral and Cellular Aspects of Inflammation and Inhibition of Inflammation. H. Bekemeier and R. Hirschelman, editors. Halle, Saale, GDR. 69?78."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1440-1681.1985.tb02322.x","volume":"12","author":"B. Jackson","year":"1985","unstructured":"Jackson, B., D. White, R. Cubela, andR. Helme. 1985. Angiotensin converting enzyme and substance P changes in blister fluid following afferent nerve stimulation in the rat.Clin. Exp. Pharmacol. Physiol. 12:187?191.","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"CR30","first-page":"1323","volume":"314","author":"P. Devillier","year":"1986","unstructured":"Devillier, P., B. Weill, M. Renoux, C. Menkes, andP. Pradelles. 1986. Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with inflammatory rheumatic diseases.N. Engl. J. Med. 314:1323.","journal-title":"N. Engl. J. Med."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1748-1716.1986.tb07783.x","volume":"126","author":"C. E. Jonsson","year":"1986","unstructured":"Jonsson, C. E., E. Brodin, C. J. Dalsgaard, andA. Haegerstrand. 1986. Release of substance-P-like immunoreactivity in dog paw lymph after scalding injury.Acta Physiol. Scand. 126:21?24.","journal-title":"Acta Physiol. Scand."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2340\/00015555662328","volume":"66","author":"J. Wallengren","year":"1986","unstructured":"Wallengren, J., R. Ekman, andH. Moller. 1986. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.Acta Dermatol. Venereol., Stock. 66:23?28.","journal-title":"Acta Dermatol. Venereol., Stock."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3940(86)90373-3","volume":"63","author":"R. D. Helme","year":"1986","unstructured":"Helme, R. D., G. M. Koschorke, andM. Zimmermann. 1986. Immunoreactive substance P release from skin nerves in the rat by noxious thermal stimulation.Neurosci. Lett. 63:295?299.","journal-title":"Neurosci. Lett."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/ac00284a003","volume":"57","author":"P. Pradelles","year":"1985","unstructured":"Pradelles, P., J. Grassi, andJ. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay.Anal. Chem. 57:1170?1173.","journal-title":"Anal. Chem."},{"key":"CR35","first-page":"125","volume-title":"Trends in Cluster Headaches","author":"D. Renzi","year":"1987","unstructured":"Renzi, D., J. Y. Couraud, Y. Frobert, M. C. Nevers, P. Geppeti, P. Pradelles, andJ. Grassi. 1987. Enzyme immunoassay for substance P using acetylcholinesterase as label.In Trends in Cluster Headaches. F. Sicuteri et al., editors. Elsevier, B.V., Amsterdam. 125?134."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1432-1033.1976.tb10841.x","volume":"68","author":"J. Massoulie","year":"1976","unstructured":"Massoulie, J., andS. Bon. 1976. Affinity chromatography of acetylcholine esterase. The importance of hydrophobic interactions.Eur. J. Biochem. 68:531?539.","journal-title":"Eur. J. Biochem."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1016\/S0021-9258(17)39388-2","volume":"260","author":"J. Y. Couraud","year":"1985","unstructured":"Couraud, J. Y., E. Escher, D. Regoli, V. Imhoff.B. Rossignol, andP. Pradelles. 1985. Anti-substance P anti-idiotypic antibodies. Characterization and biological activities.J. Biol. Chem. 260:9461?9469.","journal-title":"J. Biol. Chem."},{"key":"CR38","unstructured":"Giroud, J. P., D. A.Willoughby, and C. J.Dunn. 1975. Investigation of prostaglandins and other mediators in various inflammatory exudates.In Physiopathologie de l'Articulation. F. Delbarre, editor, INSERM Symposium, Paris.48:63?74."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01966837","volume":"14","author":"M. Tissot","year":"1984","unstructured":"Tissot, M., C. Bonne, B. Martin, M. Solier, andJ. P. Giroud. 1984. Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.Agents Actions 14:76?81.","journal-title":"Agents Actions"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00916341","volume":"9","author":"M. Tissot","year":"1985","unstructured":"Tissot, M., D. Regoli, andJ. P. Giroud. 1985. Bradykinin levels in inflammatory exudates.Inflammation 9:419?424.","journal-title":"Inflammation"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01967311","volume":"13","author":"J. Foreman","year":"1983","unstructured":"Foreman, J., andC. Jordan. 1983. Histamine release and vascular changes induced by neuropeptides.Agents Actions 13:105?116.","journal-title":"Agents Actions"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00569651","volume":"333","author":"K. Iverfeldt","year":"1986","unstructured":"Iverfeldt, K., L. L. Peterson, E. Brodin, S. O. Ogren, andT. Bartfai. 1986. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.Arch. Pharmacol. 333:1?6.","journal-title":"Arch. Pharmacol."},{"key":"CR43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1254\/jjp.41.427","volume":"41","author":"M. Shibata","year":"1986","unstructured":"Shibata, M., T. Ohkubo, H. Takahashi, andR. Inoki. 1986. Interaction of Bradykinin with substance P on vascular permeability and pain response.Jpn. J. Pharmacol. 41:427?429.","journal-title":"Jpn. J. Pharmacol."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.4049\/jimmunol.136.10.3856","volume":"136","author":"H. P. Hartung","year":"1986","unstructured":"Hartung, H. P., K. Wolters, andK. V. Toyka. 1986. Substance P: Binding properties and studies on cellular responses in guinea pig macrophages.J. Immunol. 136:3856?3863.","journal-title":"J. Immunol."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00915889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00915889\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00915889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T23:05:30Z","timestamp":1705532730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00915889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,2]]}},"alternative-id":["BF00915889"],"URL":"https:\/\/doi.org\/10.1007\/bf00915889","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,2]]}}}